Sandler, Alan
Genentech, Inc,
United States
2024 Rank: 37233
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 1183 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 37233 | 42957 |
| Total Cites | 3217 | 3299 |
| H-index | 18 | 18 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 151 | 151 |
| Number of Single+First+Last Authored Papers | 95 | 95 |
| Total Cites to Single+First+Last Authored Papers | 220 | 223 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2215 | 2241 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.47 |
| Self-Citation Percentage |
2.49%
|
|
Sandler, Alan
Genentech, Inc,
United States
2023 Rank: 31022
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 1096 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 31022 | 35470 |
| Total Cites | 3508 | 3609 |
| H-index | 19 | 19 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 8 | 8 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 203 | 204 |
| Number of Single+First+Last Authored Papers | 95 | 95 |
| Total Cites to Single+First+Last Authored Papers | 323 | 328 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2356 | 2397 |
| Ratio of Total Citations to Distinct Citing Papers | 1.49 | 1.51 |
| Self-Citation Percentage |
2.80%
|
|
Sandler, Alan
Genentech Incorporated,
United States
2022 Rank: 30254
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 1130 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 30254 | 34462 |
| Total Cites | 3627 | 3747 |
| H-index | 21 | 22 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 188 | 188 |
| Number of Single+First+Last Authored Papers | 95 | 95 |
| Total Cites to Single+First+Last Authored Papers | 288 | 289 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2374 | 2420 |
| Ratio of Total Citations to Distinct Citing Papers | 1.53 | 1.55 |
| Self-Citation Percentage |
3.20%
|
|
Sandler, Alan
Genentech Incorporated,
United States
2021 Rank: 32707
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
General & Internal Medicine
Rank in SubField 1: 1174 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32707 | 37698 |
| Total Cites | 5229 | 5443 |
| H-index | 23 | 23 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 314 | 316 |
| Number of Single+First+Last Authored Papers | 95 | 95 |
| Total Cites to Single+First+Last Authored Papers | 459 | 462 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3438 | 3526 |
| Ratio of Total Citations to Distinct Citing Papers | 1.52 | 1.54 |
| Self-Citation Percentage |
3.93%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.